Show simple item record

dc.contributor.editorDuCros, Philipp
dc.contributor.editorHussain, Hamidah
dc.contributor.editorViney, Kerri
dc.date.accessioned2022-03-21T16:30:41Z
dc.date.available2022-03-21T16:30:41Z
dc.date.issued2022
dc.identifierONIX_20220321_9783036525518_113
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/79677
dc.description.abstractThe World Health Organization’s (WHO) END-TB strategy has set the world on course to climb the highest of medical mountains by 2035, with a targeted peak of reductions in TB deaths by 95%, TB cases by 90%, and no burdens of catastrophic expenses on families due to TB. Eliminating TB in the Asia-Pacific region, which has 62% of all estimated TB patients globally, will require innovation, rigorous research, and sustained investment. This special issue connects original research and viewpoints on pertinent approaches for improving TB care and prevention in the Asia-Pacific region.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::N History and Archaeology::NH Historyen_US
dc.subject.classificationthema EDItEUR::J Society and Social Sciences::JB Society and culture: general::JBF Social and ethical issuesen_US
dc.subject.otherpediatric TB
dc.subject.otherverbal screening
dc.subject.othercontact tracing
dc.subject.otherresources
dc.subject.othersputum
dc.subject.otherhealth promotion
dc.subject.otheroperational research
dc.subject.otherindigenous population
dc.subject.othermultidrug-resistant tuberculosis
dc.subject.otherhousehold contact
dc.subject.otherscreening
dc.subject.otherTB diagnosis
dc.subject.otheryield
dc.subject.otheroperations research
dc.subject.othercontacts
dc.subject.othercontact investigation
dc.subject.otherMDR-TB
dc.subject.otherpublic–private mix model
dc.subject.otherpublic–private partnership
dc.subject.othermissing cases
dc.subject.otherSORT IT
dc.subject.otherTB diagnostics
dc.subject.otherlaboratory methods
dc.subject.othercase detection
dc.subject.otherXpert Ultra
dc.subject.otherSTR
dc.subject.otherBangladesh regimen
dc.subject.othertuberculosis
dc.subject.otherpost-tuberculosis morbidity and mortality
dc.subject.otherTB preventive therapy
dc.subject.otherlatent TB infection
dc.subject.otherAsia Pacific
dc.subject.otherrifapentine-isoniazid
dc.subject.otherincidence
dc.subject.otherhousehold contacts tracing
dc.subject.otherEnd TB
dc.subject.othersustainable development goals
dc.subject.otherSouth-East Asia
dc.subject.otherWestern Pacific Region
dc.subject.othernational TB program
dc.subject.othersocio-economic determinants
dc.subject.otherdiabetes mellitus
dc.subject.otherTB-DM
dc.subject.otheradverse drug reactions
dc.subject.otherunfavourable outcome
dc.subject.otherlymph node TB
dc.subject.otherbone TB
dc.subject.otherTB elimination
dc.subject.otherextrapulmonary tuberculosis
dc.subject.otherprivate sector
dc.subject.otherintermediary agency
dc.subject.otherreferral
dc.subject.othernotification
dc.subject.otherViet Nam
dc.subject.otheractive case finding
dc.subject.othercommunity outreach
dc.subject.otherIndonesia
dc.subject.otherkey population
dc.subject.otherinnovation
dc.subject.otherTB REACH
dc.subject.othercommunity health workers
dc.subject.othermobile X-ray screening
dc.subject.otherTB
dc.subject.otherchest X-ray
dc.subject.otheractive TB case-finding
dc.subject.otherdiagnostic algorithm
dc.subject.othern/a
dc.titleInnovation and Evidence for Achieving TB Elimination in the Asia–Pacific Region
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-2550-1
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036525518
oapen.relation.isbn9783036525501
oapen.pages238
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/